Functional variants of lipid level modifier MLXIPL, GCKR, GALNT2, CILP2, ANGPTL3 and TRIB1 genes in healthy Roma and Hungarian populations. (Q54297946)

27 May 2018

title

Functional variants of lipid level modifier MLXIPL, GCKR, GALNT2, CILP2, ANGPTL3 and TRIB1 genes in healthy Roma and Hungarian populations. (English)

1 reference

27 May 2018

author name string

Katalin Sumegi

1

1 reference

27 May 2018

Luca Jaromi

2

1 reference

27 May 2018

Lili Magyari

3

1 reference

27 May 2018

Erzsebet Kovesdi

4

1 reference

27 May 2018

Balazs Duga

5

1 reference

27 May 2018

Renata Szalai

6

1 reference

27 May 2018

Anita Maasz

7

1 reference

27 May 2018

Petra Matyas

8

1 reference

27 May 2018

Ingrid Janicsek

9

1 reference

27 May 2018

Bela Melegh

10

1 reference

27 May 2018

publication date

9 January 2015

1 reference

27 May 2018

Pathology Oncology Research

published in

1 reference

27 May 2018

volume

21

1 reference

27 May 2018

page(s)

743-749

1 reference

27 May 2018

issue

3

1 reference

27 May 2018

https://scigraph.springernature.com/pub.10.1007/s12253-014-9884-5

exact match

0 references

cites work

Polymorphism in the promoter region of the apolipoprotein A5 gene is associated with an increased susceptibility for coronary artery disease.

1 reference

https://api.crossref.org/works/10.1007%2FS12253-014-9884-5

Apolipoprotein A-V, triglycerides and risk of coronary artery disease: the prospective Epic-Norfolk Population Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-014-9884-5

Increased factor VIII coagulant activity levels in male carriers of the factor V R2 polymorphism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-014-9884-5

Apolipoprotein A5 gene IVS3+G476A allelic variant confers susceptibility for development of ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-014-9884-5

Apolipoprotein A5 gene C56G variant confers risk for the development of large-vessel associated ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-014-9884-5

Association of gene variants with lipid levels in response to fenofibrate is influenced by metabolic syndrome status

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-014-9884-5

GCKR gene functional variants in type 2 diabetes and metabolic syndrome: do the rare variants associate with increased carotid intima-media thickness?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-014-9884-5

Functional variants of glucokinase regulatory protein and apolipoprotein A5 genes in ischemic stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-014-9884-5

Triglyceride level-influencing functional variants of the ANGPTL3, CILP2, and TRIB1 loci in ischemic stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-014-9884-5

Allelic and phenotypic spectrum of plasma triglycerides

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-014-9884-5

Polymorphisms in APOA1 and LPL genes are statistically independently associated with fasting TG in men with CAD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-014-9884-5

Apolipoprotein A5 gene promoter region T-1131C polymorphism associates with elevated circulating triglyceride levels and confers susceptibility for development of ischemic stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-014-9884-5

Nonfasting triglycerides and risk of ischemic stroke in the general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-014-9884-5

Newly identified loci that influence lipid concentrations and risk of coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-014-9884-5

Common variants at 30 loci contribute to polygenic dyslipidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-014-9884-5

Plasma triglyceride levels and risk of stroke and carotid atherosclerosis: a systematic review of the epidemiological studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-014-9884-5

Nutrigenetics of the postprandial lipoprotein metabolism: evidences from human intervention studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-014-9884-5

Variants identified in a GWAS meta-analysis for blood lipids are associated with the lipid response to fenofibrate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-014-9884-5

Approach to lipoprotein management in 2001 National Cholesterol Guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-014-9884-5

Variants in the APOA5 gene region and the response to combination therapy with statins and fenofibric acid in a randomized clinical trial of individuals with mixed dyslipidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-014-9884-5

Apolipoprotein A5 IVS3+476A allelic variant associates with increased trigliceride levels and confers risk for development of metabolic syndrome in Hungarians

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-014-9884-5

Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-014-9884-5

ANGPTL3 decreases very low density lipoprotein triglyceride clearance by inhibition of lipoprotein lipase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-014-9884-5

Identification of a novel locus for triglyceride on chromosome 1p31-32 in families with premature CAD and MI

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-014-9884-5

The Association between genetic variations of CHI3L1, levels of the encoded glycoprotein YKL-40 and the lipid profile in a Danish population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-014-9884-5

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-014-9884-5

Fasting and postchallenge glycemia and cardiovascular disease risk: the Framingham Offspring Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-014-9884-5

Apolipoprotein A5, a newly identified gene that affects plasma triglyceride levels in humans and mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-014-9884-5

Association of apolipoprotein E gene polymorphism with ischemic stroke involving large-vessel disease and its relation to serum lipid levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-014-9884-5

Reconstructing Roma history from genome-wide data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-014-9884-5

A simple salting out procedure for extracting DNA from human nucleated cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-014-9884-5

The common P446L polymorphism in GCKR inversely modulates fasting glucose and triglyceride levels and reduces type 2 diabetes risk in the DESIR prospective general French population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-014-9884-5

Associations of apolipoprotein A5 (APOA5), glucokinase (GCK) and glucokinase regulatory protein (GCKR) polymorphisms and lifestyle factors with the risk of dyslipidemia and dysglycemia in Japanese - a cross-sectional data from the J-MICC Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-014-9884-5

APOA5 Q97X mutation identified through homozygosity mapping causes severe hypertriglyceridemia in a Chilean consanguineous family

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-014-9884-5

Human glucokinase regulatory protein (GCKR): cDNA and genomic cloning, complete primary structure, and chromosomal localization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-014-9884-5

Organization of the human glucokinase regulator gene GCKR

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-014-9884-5

Common missense variant in the glucokinase regulatory protein gene is associated with increased plasma triglyceride and C-reactive protein but lower fasting glucose concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-014-9884-5

Evaluation of seven common lipid associated loci in a large Indian sib pair study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-014-9884-5

Mutations in the glucokinase regulatory protein gene in 2p23 in obese French caucasians

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-014-9884-5

Variant in the glucokinase regulatory protein (GCKR) gene is associated with fatty liver in obese children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-014-9884-5

Characterization of three kindreds with familial combined hypolipidemia caused by loss-of-function mutations of ANGPTL3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-014-9884-5

Effects of genetic variants on lipid parameters and dyslipidemia in a Chinese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-014-9884-5

Polymorphisms at newly identified lipid-associated loci are associated with blood lipids and cardiovascular disease in an Asian Malay population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-014-9884-5

Apolipoprotein A5 T-1131C variant confers risk for metabolic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-014-9884-5

The −1131 T>C and S19W APOA5 gene polymorphisms are associated with high levels of triglycerides and apolipoprotein C-III, but not with coronary artery disease: an angiographic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-014-9884-5

Impact of variants within seven candidate genes on statin treatment efficacy

21 January 2018

1 reference

12 December 2020

The paradox of ApoA5 modulation of triglycerides: evidence from clinical and basic research

1 reference

12 December 2020

Risk factors, biochemical markers, and genetic polymorphisms in early coronary artery disease

1 reference

12 December 2020

A common haplotype at the CD36 locus is associated with high free fatty acid levels and increased cardiovascular risk in Caucasians

1 reference

12 December 2020

10.1007/S12253-014-9884-5

Identifiers

DOI

1 reference

27 May 2018

PubMed ID

25573592

1 reference

27 May 2018